MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Dandy-Walker syndrome. A case study.

    GM. Mussagaliyeva (Almaty, Kazakhstan)

    Objective: Present a case study with rare congenital disease for further сreating a database and developing algorithms for the management of such cases in the…
  • 2024 International Congress

    A Phase 2 Study of ATH434 a Novel Inhibitor of α-Synuclein Aggregation for the Treatment of Multiple System Atrophy

    D. Stamler, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, D. Claassen (Newark, USA)

    Objective: Describe baseline fluid and neuroimaging biomarker data of an early MSA study population Background: MSA is a rapidly progressive neurodegenerative disorder characterized by aggregated…
  • 2024 International Congress

    Seed Amplification Assay for the differentiation of αSyn seed subtypes

    C. Farris, S. Weber, Y. Ma, H. Nguyen, S. Rosete-Gonzalez, A. Siderowf, U. Kang, B. Mollenhauer, L. Concha-Marambio (san diego, USA)

    Objective: To identify soluble αSyn-seed types present in brain homogenate (BH) and CSF using αSyn seed amplification assay (synSAA) Background: Lewy bodies and neurites are…
  • 2024 International Congress

    Increasing diagnostic accuracy of Multiple System Atrophy – A Videolibrary on clinical and imaging features

    V. Sidoroff, A. Antonini, A. Batla, N. Bendahan, G. Calandra Buonaura, N. Campese, G. da Prat, M. Fabbri, A. Fanciulli, J. Ferreira, F. Gandor, D. Goldstein, T. Gurevich, S. Katzdobler, H. Kaufmann, J. Klempir, V. Kostic, F. Krismer, V. Khurana, A. Lang, J. Levin, N. Mcfarland, P. Millar Vernetti, M. Pellecchia, I. Petrovic, W. Poewe, N. Quinn, C. Raccagni, R. Moiron Simões, W. Singer, M. Michael Strupp, M. Stamelou, G. Höglinger, G. Wenning, I. Stankovic (Innsbruck, Austria)

    Objective: To provide short, high-quality videos and MRI images presenting typical MSA features to supplement new MDS-MSA criteria1. Background: The MDS criteria for the diagnosis…
  • 2024 International Congress

    Peripheral immune profile and neutrophil-to-lymphocyte ratio in Progressive Supranuclear Palsy

    L. Muñoz-Delgado, A. Luque-Ambrosiani, B. Benítez Zamora, D. Macías-García, S. Jesús, AD. Adarmes‐gómez, E. Ojeda-Lepe, F. Carrillo, P. Mir (Sevilla, Spain)

    Objective: This study aimed to evaluate the peripheral immune profile in patients with Progressive Supranuclear Palsy (PSP) compared with patients with Parkinson’s disease (PD) and…
  • 2024 International Congress

    The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

    L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)

    Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…
  • 2024 International Congress

    Impact of Prior Head Trauma on Parkinson’s Disease Experience

    S. Vallamkonda, A. Hohler (Boston, USA)

    Objective: We aim to characterize the impact of prior head trauma on Parkinson’s disease (PD) related outcomes. Background: Previous head trauma is correlated with detrimental…
  • 2024 International Congress

    Preventing Treatment Disruptions: The Crucial Role of Outpatient Nurses and Multidisciplinary Collaboration in Managing Skin Complications during Foslevodopa/Foscarbidopa Therapy

    T. Kojiri, N. Nishikawa, Y. Uchida, M. Nozaki, N. Yoshihara, S. Ueno, G. Oyama, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: The objective of this research was to explore the pivotal role of outpatient nurses in mitigating skin complications and facilitating uninterrupted treatment for Parkinson's…
  • 2024 International Congress

    EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

    R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)

    Objective: To determine whether cognitive performance correlates with posterior dominant frequency across Lewy body diseases. Background: DLB and PDD are associated with prominent posterior slow-wave…
  • 2024 International Congress

    SARS-CoV-2 induced neurodegeneration in oxidative stress and genetic models of Parkinson’s Disease

    D. Chatterjee, T. Rodriguez, K. Crowther, M. Byrne, R. Smeyne (Philadelphia, USA)

    Objective: Given similarities in systemic responses after infection with SARS-CoV-2 to those reported after the 1918 pandemic, we investigated whether SARS-CoV-2 could elicit a similar…
  • « Previous Page
  • 1
  • …
  • 168
  • 169
  • 170
  • 171
  • 172
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley